Notably, SHED-derived CM was able to improve motor performance in PD rats, reducing neuroinflammation (Iba1 and CD4 levels), increasing TH amounts in the striatum, and decreasing α-synuclein levels in both the substantia nigra and striatum [67]. This evidence concerns the gene TH and Parkinson disease.